aid: rapport-therapeutics
name: Rapport Therapeutics
description: >-
  Rapport Therapeutics, Inc. (Nasdaq: RAPP) is a clinical-stage biotechnology company headquartered in
  Boston, Massachusetts with research operations in San Diego, California, founded in 2022 and taken
  public in a $174 million IPO in June 2024. Rapport develops precision small-molecule medicines for
  central nervous system disorders using its proprietary RAP technology platform, which pairs human
  genetics with functional proteomics to identify receptor-associated proteins that confer
  neuroanatomical specificity — the goal being drugs that act only where the disease circuit lives
  rather than across the whole brain. Its lead clinical candidate, RAP-219, is a selective negative
  allosteric modulator of TARP-gamma-8-associated AMPA receptors in development for focal onset
  seizures, peripheral neuropathic pain and bipolar disorder, behind two discovery-stage nicotinic
  acetylcholine receptor programs targeting alpha-6 (chronic pain) and alpha-9-alpha-10 (hearing
  disorders). Rapport is a therapeutics developer, not a software vendor: the RAP platform is an
  internal discovery capability and the company publishes no developer program, no public API and no
  machine-readable API contract.
url: https://raw.githubusercontent.com/api-evangelist/rapport-therapeutics/refs/heads/main/apis.yml
x-api-posture: no-product-api
x-api-posture-basis: observed
x-api-posture-note: "Rapport is a therapeutics developer, not a software vendor: the RAP platform is an internal discovery capability and the company publishes no developer program, no public API and no machine-readable A"
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
image: https://www.rapportrx.com/wp-content/uploads/2023/02/rapportrx-yoast-logo.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Healthcare
- Neuroscience
- Central Nervous System
- Drug Discovery
- Clinical Trials
- Epilepsy
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/rapport-therapeutics-domain-security.yml
- type: Website
  url: https://www.rapportrx.com/
- type: About
  url: https://www.rapportrx.com/about/
- type: Support
  url: https://www.rapportrx.com/contact/
- type: PrivacyPolicy
  url: https://www.rapportrx.com/privacy-policy/
- type: TermsOfService
  url: https://www.rapportrx.com/terms-of-use/
- type: BlogRSS
  url: https://www.rapportrx.com/feed/
- type: LinkedIn
  url: https://www.linkedin.com/company/rapport-therapeutics/
- type: LLMsTxt
  url: llms/rapport-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Rapport Therapeutics is a clinical-stage CNS drug developer whose product is a molecule pipeline
    (RAP-219 plus two discovery nAChR programs); www.rapportrx.com is a seventeen-page WordPress
    marketing site where every contract-discovery path — /openapi.json, /swagger.json, /api-docs,
    /graphql, /llms.txt and all seven /.well-known/ paths — returns 404, no api/developer/docs
    subdomain resolves, the RAP platform is an internal discovery capability that is never exposed,
    and the only machine-readable surface on the domain is the CMS's default, unadvertised /wp-json/
    index describing pages and posts rather than a product API.
  evidence:
  - url: https://www.rapportrx.com/openapi.json
    status: 404
  - url: https://www.rapportrx.com/graphql
    status: 404
  - url: https://www.rapportrx.com/.well-known/api-catalog
    status: 404
  - url: https://www.rapportrx.com/.well-known/agent-card.json
    status: 404
  - url: https://www.rapportrx.com/llms.txt
    status: 404
  - url: https://developer.rapportrx.com/
    status: 0
  - url: https://investors.rapportrx.com/
    status: 0
  checked: '2026-08-26'